SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-21-007220
Filing Date
2021-05-14
Accepted
2021-05-14 11:00:13
Documents
2
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp147785_3-fazeli.html 3  
1 FORM 3 dp147785_3-fazeli.xml 3 1711
2 EXHIBIT 24.1 dp147785_ex2401.htm EX-24.1 8810
  Complete submission text file 0000950103-21-007220.txt   11866
Mailing Address JOHANNES VERMEERPLEIN 9 1071 DV AMSTERDAM P7 00000
Business Address JOHANNES VERMEERPLEIN 9 1071 DV AMSTERDAM P7 00000 31 (0) 20 664 55 00
European Biotech Acquisition Corp. (Issuer) CIK: 0001841258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV
Business Address
Fazeli Mohammad Sohail (Reporting) CIK: 0001850882 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40211 | Film No.: 21922658